← Back to Search

Behavioral Intervention

ASPIRE Intervention for High Blood Pressure

N/A
Waitlist Available
Led By Rasha Khatib, PhD
Research Sponsored by Advocate Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least a 1-year history of hypertension
Adults >=18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to create training guides for both patients and the clinical team to ensure that the treatment is given consistently to every patient.

Who is the study for?
The ASPIRE trial is for adults 18 years or older with a history of high blood pressure for at least one year. Participants must have had an elevated blood pressure reading during their qualifying visit and be on medication to lower blood pressure. They also need to be able to give consent.
What is being tested?
This study tests the ASPIRE Intervention, which involves creating training manuals and materials for patients and clinical teams aimed at consistently managing high blood pressure across different individuals.
What are the potential side effects?
Since this trial focuses on developing educational materials rather than testing new medications, there are no direct side effects from drugs being studied. However, changes in how participants manage their blood pressure could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had high blood pressure for at least a year.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
SMBP Feasibility
Secondary study objectives
Blood pressure control
Change in diastolic blood pressure (DBP)
Change in systolic blood pressure (SBP)
+1 more
Other study objectives
Patient and Care Team Acceptability
Patients and Care Team Satisfaction

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ASPIRE Intervention ArmExperimental Treatment1 Intervention
The intervention arm will receive usual care, a free blood pressure cuff in addition to the ASPIRE Components.
Group II: Control ArmActive Control1 Intervention
The control group will receive usual care and a free blood pressure cuff.

Find a Location

Who is running the clinical trial?

Advocate Health CareLead Sponsor
56 Previous Clinical Trials
1,414,679 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,478,295 Total Patients Enrolled
Rasha Khatib, PhDPrincipal InvestigatorAdvocate Aurora Research Institute
~21 spots leftby Jan 2026